The role of RhoC in ovarian epithelial carcinoma: A marker for carcinogenesis, progression, prognosis, and target therapy

Gynecologic Oncology

Volumn 130, Issue 3, 2013, Pages 570-578

  Zhao, Yang ^a   Zheng, Hua Chuan ^a   Chen, Shuo ^a   Gou, Wen Feng ^a   Xiao, Li Jun ^a   Niu, Zhe Feng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Aggressive phenotypes; Ovarian carcinoma; P70S6 kinase; Pathobiological behavior; Prognosis; RhoC

Indexed keywords

CASPASE 3; GELATINASE B; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; MEVINOLIN; PHOSPHOTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN RHOC; SMALL INTERFERING RNA; STAT3 PROTEIN; SURVIVIN; TUMOR MARKER; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; APOPTOSIS; ARTICLE; BENIGN TUMOR; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER THERAPY; CANCER TISSUE; CARCINOGENESIS; CELL DEDIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAMELLIPODIUM; MAJOR CLINICAL STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; OVARY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; WESTERN BLOTTING; WOUND HEALING;

AGGRESSIVE PHENOTYPES; OVARIAN CARCINOMA; P70S6 KINASE; PATHOBIOLOGICAL BEHAVIOR; PROGNOSIS; RHOC;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CASPASE 3; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INHIBITOR OF APOPTOSIS PROTEINS; LOVASTATIN; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARY; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RHO GTP-BINDING PROTEINS; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; TISSUE ARRAY ANALYSIS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84882455755     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.06.004     Document Type: Article

References (25)

1. J.M. Piek, P. Kenemans, R.P. Zweemer, P.J. van Diest, and R.H. Verheijen Ovarian carcinogenesis, an alternative theory Gynecol Oncol 107 2 Nov 2007 355
2. J.M. Piek, P.J. van Diest, and R.H. Verheijen Ovarian carcinogenesis: an alternative hypothesis Adv Exp Med Biol 622 2008 79 87
3. A.J. Ridley Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking Trends Cell Biol 16 10 2006 522 529
4. T.M. Kitzing, Y. Wang, O. Pertz, J.W. Copeland, and R. Grosse Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC Oncogene 29 16 2010 2441 2448
5. A. Hakem, O. Sanchez-Sweatman, A. You-Ten, G. Duncan, A. Wakeham, and R. Khokha RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis Genes Dev 19 17 2005 1974 1979
6. Y. Wu, Y. Tao, Y. Chen, and W. Xu RhoC regulates the proliferation of gastric cancer cells through interaction with IQGAP1 PLoS One 7 11 2012 e48917
7. N. Liu, G. Zhang, F. Bi, Y. Pan, Y. Xue, and Y. Shi RhoC is essential for the metastasis of gastric cancer J Mol Med 85 10 2007 1149 1156
8. M. Islam, G. Lin, J.C. Brenner, Q. Pan, S.D. Merajver, and Y. Hou RhoC expression and head and neck cancer metastasis Mol Cancer Res 7 11 2009 1771 1780
9. H. Abe, T. Kamai, T. Tsujii, F. Nakamura, T. Mashidori, and T. Mizuno Possible role of the RhoC/ROCK pathway in progression of clear cell renal cell carcinoma Biomed Res 29 3 2008 155 161
10. B. Boone, M. Van Gele, J. Lambert, M. Haspeslagh, and L. Brochez The role of RhoC in growth and metastatic capacity of melanoma J Cutan Pathol 36 6 2009 629 636
11. C.G. Kleer, T.N. Teknos, M. Islam, B. Marcus, J.S. Lee, and Q. Pan RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck Clin Cancer Res 12 15 2006 4485 4490
12. Y. Zhao, Z.H. Zong, and H.M. Xu RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9 Gynecol Oncol 116 3 2010 563 571
13. T. Kumada, K. Tsuneyama, H. Hatta, S. Ishizawa, and Y. Takano Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital Mod Pathol 17 9 2004 1141 1149
14. W.B. Zhong, Y.C. Liang, C.Y. Wang, T.C. Chang, and W.S. Lee Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling Endocr Relat Cancer 12 3 2005 615 629
15. X. He, Y. Qian, H. Cai, and Z. Wang The effect of RhoC siRNA on the invasiveness and proliferation of human cervical cancer cell line SiHa cells J Huazhong Univ Sci Technolog Med Sci 28 6 2008 665 669
16. W. Wang, F. Wu, F. Fang, Y. Tao, and L. Yang Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo Clin Cancer Res 14 21 2008 6804 6812
17. Z. Shi, M.L. Chen, Q.L. He, and J.H. Zeng Antisense RhoC gene suppresses proliferation and invasion capacity of human QBC939 cholangiocarcinoma cells Hepatobiliary Pancreat Dis Int 6 5 2007 516 520
18. M. Iiizumi, S. Bandyopadhyay, S.K. Pai, M. Watabe, S. Hirota, and S. Hosobe RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer Cancer Res 68 18 2008 7613 7620
19. M. Mukai, H. Endo, T. Iwasaki, M. Tatsuta, A. Togawa, and H. Nakamura RhoC is essential for TGF-beta1-induced invasive capacity of rat ascites hepatoma cells Biochem Biophys Res Commun 346 1 2006 74 82
20. S. Xie, M. Zhu, G. Lv, Q. Zhang, and G. Wang The role of RhoC in the proliferation and apoptosis of hepatocellular carcinoma cells Med Oncol 29 3 2012 1802 1809
21. G. Koch, C. Benz, G. Schmidt, C. Olenik, and K. Aktories Role of Rho protein in lovastatin-induced breakdown of actin cytoskeleton J Pharmacol Exp Ther 283 2 1997 901 909
22. W.B. Zhong, S.P. Hsu, P.Y. Ho, Y.C. Liang, T.C. Chang, and W.S. Lee Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway Biochem Pharmacol 82 11 2011 1663 1672
23. R.L. Maddala, V.N. Reddy, and P.V. Rao Lovastatin-induced cytoskeletal reorganization in lens epithelial cells: role of Rho GTPases Invest Ophthalmol Vis Sci 42 11 2001 2610 2615
24. H.L. Lehman, S.J. Van Laere, C.M. van Golen, P.B. Vermeulen, L.Y. Dirix, and K.L. van Golen Regulation of inflammatory breast cancer cell invasion through Akt1/PKBαphosphorylation of RhoC GTPase Mol Cancer Res 10 10 2012 1306 1318
25. M.C. Ruth, Y. Xu, I.H. Maxwell, N.G. Ahn, D.A. Norris, and Y.G. Shellman RhoC promotes human melanoma invasion in a PI3K/Akt-dependent pathway J Invest Dermatol 126 4 2006 862 868